The Pleiotropic Effects of miRNAs on Tumor Angiogenesis
Identifieur interne : 000D71 ( Main/Exploration ); précédent : 000D70; suivant : 000D72The Pleiotropic Effects of miRNAs on Tumor Angiogenesis
Auteurs : Runting Yin [République populaire de Chine] ; Le Guo [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Junnian Zheng [République populaire de Chine]Source :
- Journal of Cellular Biochemistry [ 0730-2312 ] ; 2015-09.
Abstract
Angiogenesis, the process of new blood vessel formation and growth from already existing venules is critical in vascular development and homeostasis controlled by the balance of pro‐ and anti‐angiogenic factors. Emerging evidence indicates the development, progression, and metastasis of various human cancers are strongly relied on angiogenesis. However, molecular mechanisms that underlie the complex regulation of angiogenic processes are still not fully elucidated. Recent studies revealed that microRNAs (miRNAs) were important regulators of tumor angiogenesis and the entire research in this area has entered into a so‐called “miRNAs era.” Thus, miRNAs might be important therapeutic targets or biomarkers for cancer. Due to the complexity of miRNA regulating mechanisms, how specific miRNAs intersect with and modulate tumor angiogenesis is still unclear. The conflicting results of the same miRNAs from different groups indicated that miRNAs might possess potent activity in a cell type or cell context specific manner. Here, we present a summary of latest advances in understanding the roles of angiogenic miRNAs as potential tools or targets in cancer therapy. J. Cell. Biochem. 116: 1807–1815, 2015. © 2013 Wiley Periodicals, Inc.
Url:
DOI: 10.1002/jcb.24679
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C48
- to stream Istex, to step Curation: 000C27
- to stream Istex, to step Checkpoint: 000091
- to stream Main, to step Merge: 000D72
- to stream Main, to step Curation: 000D71
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Pleiotropic Effects of miRNAs on Tumor Angiogenesis</title><author><name sortKey="Yin, Runting" sort="Yin, Runting" uniqKey="Yin R" first="Runting" last="Yin">Runting Yin</name></author><author><name sortKey="Guo, Le" sort="Guo, Le" uniqKey="Guo L" first="Le" last="Guo">Le Guo</name></author><author><name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name></author><author><name sortKey="Zheng, Junnian" sort="Zheng, Junnian" uniqKey="Zheng J" first="Junnian" last="Zheng">Junnian Zheng</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D2258D427D4DB6E80896B3F44CA8E710B37A3DB4</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1002/jcb.24679</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-4KVDLWZ5-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000C48</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C48</idno><idno type="wicri:Area/Istex/Curation">000C27</idno><idno type="wicri:Area/Istex/Checkpoint">000091</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000091</idno><idno type="wicri:doubleKey">0730-2312:2015:Yin R:the:pleiotropic:effects</idno><idno type="wicri:Area/Main/Merge">000D72</idno><idno type="wicri:Area/Main/Curation">000D71</idno><idno type="wicri:Area/Main/Exploration">000D71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">The Pleiotropic Effects of miRNAs on Tumor Angiogenesis</title><author><name sortKey="Yin, Runting" sort="Yin, Runting" uniqKey="Yin R" first="Runting" last="Yin">Runting Yin</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001</wicri:regionArea><wicri:noRegion>Nantong 226001</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Jiangsu Province Key Laboratory of Tumor Biological Therapy, Xuzhou Medical College, Xuzhou 221000</wicri:regionArea><wicri:noRegion>Xuzhou 221000</wicri:noRegion></affiliation><affiliation></affiliation><affiliation></affiliation></author><author><name sortKey="Guo, Le" sort="Guo, Le" uniqKey="Guo L" first="Le" last="Guo">Le Guo</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>School of Laboratory Medicine, Ningxia Medical University, 750004, Yinchuan</wicri:regionArea><wicri:noRegion>Yinchuan</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Nantong University, Nantong 226001</wicri:regionArea><wicri:noRegion>Nantong 226001</wicri:noRegion></affiliation><affiliation></affiliation><affiliation></affiliation></author><author><name sortKey="Zheng, Junnian" sort="Zheng, Junnian" uniqKey="Zheng J" first="Junnian" last="Zheng">Junnian Zheng</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Jiangsu Province Key Laboratory of Tumor Biological Therapy, Xuzhou Medical College, Xuzhou 221000</wicri:regionArea><wicri:noRegion>Xuzhou 221000</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Cellular Biochemistry</title><title level="j" type="alt">JOURNAL OF CELLULAR BIOCHEMISTRY</title><idno type="ISSN">0730-2312</idno><idno type="eISSN">1097-4644</idno><imprint><biblScope unit="vol">116</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1807">1807</biblScope><biblScope unit="page" to="1815">1815</biblScope><biblScope unit="page-count">9</biblScope><date type="published" when="2015-09">2015-09</date></imprint><idno type="ISSN">0730-2312</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0730-2312</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Angiogenesis, the process of new blood vessel formation and growth from already existing venules is critical in vascular development and homeostasis controlled by the balance of pro‐ and anti‐angiogenic factors. Emerging evidence indicates the development, progression, and metastasis of various human cancers are strongly relied on angiogenesis. However, molecular mechanisms that underlie the complex regulation of angiogenic processes are still not fully elucidated. Recent studies revealed that microRNAs (miRNAs) were important regulators of tumor angiogenesis and the entire research in this area has entered into a so‐called “miRNAs era.” Thus, miRNAs might be important therapeutic targets or biomarkers for cancer. Due to the complexity of miRNA regulating mechanisms, how specific miRNAs intersect with and modulate tumor angiogenesis is still unclear. The conflicting results of the same miRNAs from different groups indicated that miRNAs might possess potent activity in a cell type or cell context specific manner. Here, we present a summary of latest advances in understanding the roles of angiogenic miRNAs as potential tools or targets in cancer therapy. J. Cell. Biochem. 116: 1807–1815, 2015. © 2013 Wiley Periodicals, Inc.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Yin, Runting" sort="Yin, Runting" uniqKey="Yin R" first="Runting" last="Yin">Runting Yin</name></noRegion><name sortKey="Guo, Le" sort="Guo, Le" uniqKey="Guo L" first="Le" last="Guo">Le Guo</name><name sortKey="Yin, Runting" sort="Yin, Runting" uniqKey="Yin R" first="Runting" last="Yin">Runting Yin</name><name sortKey="Zhang, Wei" sort="Zhang, Wei" uniqKey="Zhang W" first="Wei" last="Zhang">Wei Zhang</name><name sortKey="Zheng, Junnian" sort="Zheng, Junnian" uniqKey="Zheng J" first="Junnian" last="Zheng">Junnian Zheng</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D2258D427D4DB6E80896B3F44CA8E710B37A3DB4
|texte= The Pleiotropic Effects of miRNAs on Tumor Angiogenesis
}}
| This area was generated with Dilib version V0.6.33. |  |